Swiss biopharma Versameb locks in funding
Versameb AG, a Swiss biopharmaceutical company, has raised CHF 6.4 million in financing. The investors were not named.
17 October 2019•1 min read
Versameb AG, a Swiss biopharmaceutical company, has raised CHF 6.4 million in financing. The investors were not named.
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
2 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
3 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
3 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
5 hours ago · 3 mins read
LDC backs London management consultancy Moorhouse after sale by Expleo
6 hours ago · 2 mins read
PAI and ICG receive VKR Holding offer for window shutter maker StellaGroup
8 hours ago · 2 mins read
